Optimizing PreTerm Infant Ampicillin Dosing

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT07610486
Phase
PHASE1/PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Ampicillin
  • Early Onset Sepsis
  • NICU
  • Preterm Neonates
  • Safety and Pharmacokinetics

Eligibility Criteria

Sex
ALL
Age
0 Days - 7 Days
Healthy Volunteers
Not accepted

Interventions

  • Ampicillin prescribed by provider per standard of care for evaluation of early onset sepsis — DRUG
    preterm infants receive less than 48 hours of prescribed ampicillin (i.e., a "short-course" ampicillin regimen) to provide the desired 48 hours of therapeutic exposures

Study Details

The goal of this clinical trial is to learn if preterm infants who are prescribed antibiotics shortly after birth can safety receive a shorter course of antibiotics (24 to 36 hours instead of 48 hours). The main questions it aims to answer are: * Does short-course ampicillin provide high enough levels of ampicillin at 48 hours? * Is short-course ampicillin safe for preterm infants to receive? Preterm infants who are being prescribed ampicillin by their doctor and enroll in the study will stop ampicillin after a shorter than typical course, and researchers will collect blood samples to measure their ampicillin levels and follow them clinically to see how they do after receiving short-course ampicillin. Participants will: * stop ampicillin earlier than 48 hours (between 24 to 36 hours, depending on how premature they are and the dosing of ampicillin their doctor has prescribed) * have a blood sample collected around 48 hours from when they started ampicillin * have their data collected until 30 days after they receive short-course ampicillin, or until hospital discharge, whichever is sooner

Key Dates

Start date
Jul 31, 2026
Status verified
May 2026
Primary completion
Jul 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Short-course Ampicillin
    Infants enrolled in the trial receive short-course empiric ampicillin (24 to 36 hours, depending on gestational age and prescribed dosing regimen), rather than a standard (48 hour) empiric ampicillin course

Primary Outcome Measure

Free plasma ampicillin concentration [ Time Frame: data will be collected up to 50 hours from the first dose of ampicillin ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Duke Health Neonatal Intensive Care UnitDurhamNorth Carolina27705
Angelique Boutzoukas, MD, MPH
919-668-4733
Stefany Olague, MPH
Angelique Boutzoukas, MD, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Durham, NC

Related Studies